Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugates

被引：0

作者：

Satake, Noriko ^{[1
]}

Duong, Connie ^{[1
]}

Oestergaard, Michael ^{[2
]}

Yoshida, Sakiko ^{[1
]}

Chen, Cathy ^{[1
]}

Nolta, Jan A. ^{[3
]}

Guo, Shuling ^{[4
]}

Seth, Punit ^{[2
]}

Nitin, Nitin ^{[5
]}

Tuscano, Joseph ^{[6
]}

机构：

[1] Univ Calif Davis, Sacramento, CA USA

[2] ISIS, Carlsbad, CA USA

[3] Univ Calif Davis, Sacramento, CA 95817 USA

[4] Isis Pharmaceut Inc, Carlsbad, CA USA

[5] Univ Calif Davis, Davis, CA USA

[6] Univ Calif Davis, Ctr Canc, Sacramento, CA USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[21] B cell therapy with the anti-CD22 monoclonal antibody epratuzumab: comment on the editorial by St.Clair and Tedder - Reply
Tedder, Thomas F.
St. Clair, E. William
ARTHRITIS AND RHEUMATISM, 2006, 54 (07): : 2344 - 2345
[22] Pre-clinical evaluation of the anti-CD22 immunotoxin CAT-8015 in combination with chemotherapy agents for childhood B-precursor acute lymphoblastic leukemia (pre-B ALL).
Ahuja, Yachna
Stetler-Stevenson, Maryalice
Kreitman, Robert J.
Pastan, Ira
Wayne, Alan S.
BLOOD, 2007, 110 (11) : 265A - 265A
[23] Targeting CD22 in childhood B-precursor acute lymphoblastic leukemia (pre-B ALL): Pre-clinical studies and Phase I trial of the anti-CD22 immunotoxin CAT-3888 (BL22).
Wayne, Alan S.
Findley, Harry W.
Lew, Glen
Ahuja, Yachna
Gu, Lubing
Stetler-Stevenson, Maryalice
Kreitman, Robert J.
Pastan, Ira
BLOOD, 2007, 110 (11) : 262A - 262A
[24] Anti-CD19 CAR T-cell therapy post antibody treatment in adult patients with relapsed/refractory precursor B-acute lymphoblastic leukemia
Danylesko, Ivetta
Besser, Michal
Jacoby, Elad
Itzhaki, Orit
Shem-Tov, Noga
Yerushalmi, Ronit
Toren, Amos
Shimoni, Avichai
Nagler, Arnon
Avigdor, Abraham
BONE MARROW TRANSPLANTATION, 2019, 54 : 517 - 518
[25] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Jing Pan
Qing Niu
Biping Deng
Shuangyou Liu
Tong Wu
Zhiyong Gao
Zhaoli Liu
Yue Zhang
Xiaomin Qu
Yanlei Zhang
Shaohui Liu
Zhuojun Ling
Yuehui Lin
Yongqiang Zhao
Yanzhi Song
Xiyou Tan
Yan Zhang
Zhihui Li
Zhichao Yin
Bingzhen Chen
Xinjian Yu
Ju Yan
Qinlong Zheng
Xuan Zhou
Jin Gao
Alex H. Chang
Xiaoming Feng
Chunrong Tong
Leukemia, 2019, 33 : 2854 - 2866
[26] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Jing, P.
Niu, Q.
Deng, B.
Liu, S.
Wu, T.
Gao, Z.
Chang, A. H.
Feng, X.
Tong, C.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1723 - 1723
[27] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Pan, Jing
Niu, Qing
Deng, Biping
Liu, Shuangyou
Wu, Tong
Gao, Zhiyong
Liu, Zhaoli
Zhang, Yue
Qu, Xiaomin
Zhang, Yanlei
Liu, Shaohui
Ling, Zhuojun
Lin, Yuehui
Zhao, Yongqiang
Song, Yanzhi
Tan, Xiyou
Zhang, Yan
Li, Zhihui
Yin, Zhichao
Chen, Bingzhen
Yu, Xinjian
Yan, Ju
Zheng, Qinlong
Zhou, Xuan
Gao, Jin
Chang, Alex H.
Feng, Xiaoming
Tong, Chunrong
LEUKEMIA, 2019, 33 (12) : 2854 - 2866
[28] Targeted Therapy for ETV6-RUNX1-Driven B-Cell Precursor Acute Lymphoblastic Leukemia
Polak, Roel
Bierings, Marc B.
van der Leije, Cindy S.
van den Dungen, Rosanna E. S.
Sanders, Mathijs A.
Roovers, Onno
Cornelissen, Jan J.
Marchante, Joao R. M.
Pieters, Rob
den Boer, Monique L.
Buitenhuis, Miranda
BLOOD, 2014, 124 (21)
[29] One CAR can hide another: anti-CD22 CAR-T cells in relapsed or refractory acute b-lymphoblastic leukemia
Cailly, Laura
Leleu, Xavier
Moya, Niels
HEMATOLOGIE, 2020, 26 (01): : 9 - 10
[30] EXPERIENCE WITH INOTUZUMAB OZOGAMICIN FOR PEDIATRIC AND ADOLESCENT CD22-POSITIVE RELAPSED B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Mitani, Yuichi
Mizushima, Yoshitaka
Honda, Mamoru
Mori, Makiko
Fukuoka, Kohei
Oshima, Koichi
Arakawa, Yuki
Koh, Katsuyoshi
PEDIATRIC BLOOD & CANCER, 2024, 71 : S39 - S39

← 1 2 3 4 5 →